Marcin Jurga, PhD, CSO at EXO Biologics, has been working as a team leader in the fields of cell-based regenerative medicine and tissue engineering for over 15 years. Marcin Jurga has been the R&D head in biotech companies developing EVs drugs since 2011. Marcin has been a Chief Scientific Officer at EXO Biologics since the company foundation in 2019. The EXO Biologics team’s main achievements are development of the GMP-approved large-scale platform for EVs manufacturing and clinical translation of the extracellular vesicles for treatment of unmet medical needs.
Marcin Jurga, PhD
CSO at EXO Biologics. Team leader in the fields of cell-based regenerative medicine and tissue engineering
